Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic

BACKGROUND: Infection with the novel coronavirus SARS‐CoV‐2 induces antibodies that can be used as a proxy for COVID‐19. We present a repeated nationwide cross‐sectional study assessing the seroprevalence of SARS‐CoV‐2, the infection fatality rate (IFR), and infection hospitalization rate (IHR) duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tunheim, Gro, Rø, Gunnar Øyvind Isaksson, Tran, Trung, Kran, Anne‐Marte Bakken, Andersen, Jan Terje, Vaage, Eline Benno, Kolderup, Anette, Vaage, John Torgils, Lund‐Johansen, Fridtjof, Hungnes, Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652705/
https://www.ncbi.nlm.nih.gov/pubmed/34751488
http://dx.doi.org/10.1111/irv.12932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652705/
https://www.ncbi.nlm.nih.gov/pubmed/34751488
http://dx.doi.org/10.1111/irv.12932

Ejemplares similares